IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q3 2024 Holdings

Filed 2024-11-13 | 16 holdings | $261.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$154.5M6,068,12559.2%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$32.1M1,115,35212.3%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$19.7M1,025,0007.6%
Bicara Therapeutics Inc. (Bcax)(BCAX)COM055477103$14.5M568,9195.6%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$8.1M798,7573.1%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$7.8M1,472,3313.0%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$6.1M964,5002.3%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$5.8M2,541,0092.2%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$3.0M1,043,2671.1%
Tectonic Therapeutic Inc (Tecx)(TECX)COM878972108$2.5M84,1481.0%
CalciMedica, Inc. (Calc)(CALC)COM NEW38942Q202$2.3M521,1140.9%
Elevation Oncology Inc (Elev)COM28623U101$1.7M2,834,9100.7%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$1.5M886,0750.6%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM NEW57055L206$886.3K314,2860.3%
Aclaris Therapeutics Inc (Acrs)(ACRS)COM00461U105$499.6K434,4550.2%
Viracta Therapeutics Inc (Virx)COM92765F108$66.4K288,5710.0%